144 related articles for article (PubMed ID: 11002762)
1. Consistency in the observation of features used to classify duct carcinoma in situ (DCIS) of the breast.
Douglas-Jones AG; Morgan JM; Appleton MA; Attanoos RL; Caslin A; Champ CS; Cotter M; Dallimore NS; Dawson A; Fortt RW; Griffiths AP; Hughes M; Kitching PA; O'Brien C; Rashid AM; Stock D; Verghese A; Williams DW; Williams NW; Williams S
J Clin Pathol; 2000 Aug; 53(8):596-602. PubMed ID: 11002762
[TBL] [Abstract][Full Text] [Related]
2. Reproducibility of new classification schemes for the pathology of ductal carcinoma in situ of the breast.
Bethwaite P; Smith N; Delahunt B; Kenwright D
J Clin Pathol; 1998 Jun; 51(6):450-4. PubMed ID: 9771444
[TBL] [Abstract][Full Text] [Related]
3. Consistency achieved by 23 European pathologists in categorizing ductal carcinoma in situ of the breast using five classifications. European Commission Working Group on Breast Screening Pathology.
Sloane JP; Amendoeira I; Apostolikas N; Bellocq JP; Bianchi S; Boecker W; Bussolati G; Coleman D; Connolly CE; Dervan P; Eusebi V; De Miguel C; Drijkoningen M; Elston CW; Faverley D; Gad A; Jacquemier J; Lacerda M; Martinez-Penuela J; Munt C; Peterse JL; Rank F; Sylvan M; Tsakraklides V; Zafrani B
Hum Pathol; 1998 Oct; 29(10):1056-62. PubMed ID: 9781641
[TBL] [Abstract][Full Text] [Related]
4. Ductal carcinoma in situ of the breast: reproducibility of histological subtype analysis.
Scott MA; Lagios MD; Axelsson K; Rogers LW; Anderson TJ; Page DL
Hum Pathol; 1997 Aug; 28(8):967-73. PubMed ID: 9269834
[TBL] [Abstract][Full Text] [Related]
5. Pathologists' agreement with experts and reproducibility of breast ductal carcinoma-in-situ classification schemes.
Wells WA; Carney PA; Eliassen MS; Grove MR; Tosteson AN
Am J Surg Pathol; 2000 May; 24(5):651-9. PubMed ID: 10800983
[TBL] [Abstract][Full Text] [Related]
6. Histopathological grading of breast ductal carcinoma in situ: validation of a web-based survey through intra-observer reproducibility analysis.
Schuh F; Biazús JV; Resetkova E; Benfica CZ; Ventura Ade F; Uchoa D; Graudenz M; Edelweiss MI
Diagn Pathol; 2015 Jul; 10():93. PubMed ID: 26159429
[TBL] [Abstract][Full Text] [Related]
7. Cytological and architectural heterogeneity in ductal carcinoma in situ of the breast.
Quinn CM; Ostrowski JL
J Clin Pathol; 1997 Jul; 50(7):596-9. PubMed ID: 9306942
[TBL] [Abstract][Full Text] [Related]
8. A critical appraisal of six modern classifications of ductal carcinoma in situ of the breast (DCIS): correlation with grade of associated invasive carcinoma.
Douglas-Jones AG; Gupta SK; Attanoos RL; Morgan JM; Mansel RE
Histopathology; 1996 Nov; 29(5):397-409. PubMed ID: 8951484
[TBL] [Abstract][Full Text] [Related]
9. Nuclear grade and comedo necrosis of ductal carcinoma in situ as histopathological eligible criteria for the Japan Clinical Oncology Group 1505 trial: an interobserver agreement study.
Tsuda H; Yoshida M; Akiyama F; Ohi Y; Kinowaki K; Kumaki N; Kondo Y; Saito A; Sasaki E; Nishimura R; Fujii S; Homma K; Horii R; Murata Y; Itami M; Kajita S; Kato H; Kurosumi M; Sakatani T; Shimizu S; Taniguchi K; Tamiya S; Nakamura H; Kanbayashi C; Shien T; Iwata H
Jpn J Clin Oncol; 2021 Mar; 51(3):434-443. PubMed ID: 33420502
[TBL] [Abstract][Full Text] [Related]
10. Consistency of histopathological reporting of breast lesions detected by screening: findings of the U.K. National External Quality Assessment (EQA) Scheme. U. K. National Coordinating Group for Breast Screening Pathology.
Sloane JP; Ellman R; Anderson TJ; Brown CL; Coyne J; Dallimore NS; Davies JD; Eakins D; Ellis IO; Elston CW
Eur J Cancer; 1994; 30A(10):1414-9. PubMed ID: 7833094
[TBL] [Abstract][Full Text] [Related]
11. Correlation between type and grade of ductal carcinoma in situ and concomitant invasive ductal carcinoma of the breast.
Rudnicka L; Stachura J
Pol J Pathol; 2000; 51(3):137-43. PubMed ID: 11247396
[TBL] [Abstract][Full Text] [Related]
12. Reproducibility of three classification systems of ductal carcinoma in situ of the breast using a web-based survey.
Schuh F; Biazús JV; Resetkova E; Benfica CZ; Edelweiss MI
Pathol Res Pract; 2010 Oct; 206(10):705-11. PubMed ID: 20663616
[TBL] [Abstract][Full Text] [Related]
13. Assessment of necrosis and hypoxia in ductal carcinoma in situ of the breast: basis for a new classification.
Bussolati G; Bongiovanni M; Cassoni P; Sapino A
Virchows Arch; 2000 Oct; 437(4):360-4. PubMed ID: 11097360
[TBL] [Abstract][Full Text] [Related]
14. [Interobserver reproducibility in the pathologic diagnosis of borderline ductal proliferative breast diseases].
Wei B; Bu H; Zhu CR; Guo LX; Chen HJ; Zhao C; Zhang P; Chen DY; Tang Y; Jiang Y
Sichuan Da Xue Xue Bao Yi Xue Ban; 2004 Nov; 35(6):849-53. PubMed ID: 15573772
[TBL] [Abstract][Full Text] [Related]
15. Dichotomous histopathological assessment of ductal carcinoma in situ of the breast results in substantial interobserver concordance.
Van Bockstal M; Baldewijns M; Colpaert C; Dano H; Floris G; Galant C; Lambein K; Peeters D; Van Renterghem S; Van Rompuy AS; Verbeke S; Verschuere S; Van Dorpe J
Histopathology; 2018 Dec; 73(6):923-932. PubMed ID: 30168167
[TBL] [Abstract][Full Text] [Related]
16. An evaluation of ductal carcinoma in-situ of breast and its correlation with the grade of associated invasive component.
Konar K; Chatterjee U; Dutta SK
Indian J Pathol Microbiol; 2001 Jul; 44(3):297-300. PubMed ID: 12024916
[TBL] [Abstract][Full Text] [Related]
17. Immunoreactive p53 and metallothionein expression in duct carcinoma in situ of the breast. No correlation.
Douglas-Jones AG; Navabi H; Morgan JM; Jasani B
Virchows Arch; 1997 May; 430(5):373-9. PubMed ID: 9174627
[TBL] [Abstract][Full Text] [Related]
18. Low-Grade Ductal Carcinoma In Situ.
Alghamdi SA; Krishnamurthy K; Garces Narvaez SA; Algashaamy KJ; Aoun J; Reis IM; Recine MA; Jorda M; Poppiti RJ; Gomez-Fernandez CR
Am J Clin Pathol; 2020 Feb; 153(3):360-367. PubMed ID: 31769792
[TBL] [Abstract][Full Text] [Related]
19. The diagnostic challenge of low-grade ductal carcinoma in situ.
Onega T; Weaver DL; Frederick PD; Allison KH; Tosteson ANA; Carney PA; Geller BM; Longton GM; Nelson HD; Oster NV; Pepe MS; Elmore JG
Eur J Cancer; 2017 Jul; 80():39-47. PubMed ID: 28535496
[TBL] [Abstract][Full Text] [Related]
20. Computerized scene segmentation for the discrimination of architectural features in ductal proliferative lesions of the breast.
Anderson NH; Hamilton PW; Bartels PH; Thompson D; Montironi R; Sloan JM
J Pathol; 1997 Apr; 181(4):374-80. PubMed ID: 9196433
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]